Gliatech Launching Adcon-L In June At $495 Per Unit Following PMA Approval
This article was originally published in The Gray Sheet
Executive Summary
Gliatech's Adcon-L will be launched in mid-June at a price of $495 per unit following expedited FDA sign-off of a premarket approval application for the porcine-derived resorbable gel, the company reported May 28. The gel will be marketed through a network of approximately 175 independent manufacturers' agents servicing the orthopedic and neurosurgical markets, the firm says.